1-(Hydroxyimino)-2-(4-methoxyphenoxy)ethylamine, 95.0%, 5g

3,4-DIHYDRO-6-[[4-[[[3-(METHYLSULFONYL)PHENYL]METHYL]AMINO]-5-(TRIFLUOROMETHYL)-PYRIMIDIN-2-YL]AMINO]-2(1H)-QUINOLINONE, 98%, 100mg

(2-Fluoro-6-methoxy-3-methylphenyl)methanol, 98%, 500mg

Diethyl phthalate, 95.0%, 500ml

3,5-bis(trifluoromethyl)benzoylacetonitrile, 97.0%, 1g

Alverine Citrate>95.0%(HPLC)(T)1g

(3R,5S)-5-{[bis(4-methoxyphenyl)(phenyl)methoxy]methyl}pyrrolidin-3-ol, 95%, 250mg

2,6-Dibromo-3-methylpyridine, 95.0%, 500mg

L-Lysine, N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-N6-(1-oxohexadecyl)-, 97%, 1g

GC-Kapillarsäule ROTI®Cap-5, unpolar, L 10 m, Ø-Innen 0,32 mm, Filmd. 0,10 µm, 1 Stück

4-Aminophenyl trifluoromethyl sulfide, 98.0%, 100g

PHENYL PYRIDIN-3-YLCARBAMATE, 95.0%, 1g

2-(Methylamino)pentanedioic acid, 95.0%, 250mg